Table 1. Point-of-care Testing (POCT) for Inflammatory Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Point-of-care Testing (POCT) for Inflammatory Market Restraints

Table 3. Point-of-care Testing (POCT) for Inflammatory Market Trends

Table 4. Point-of-care Testing (POCT) for Inflammatory Industry Policy

Table 5. Global Point-of-care Testing (POCT) for Inflammatory Revenue by Company, 2019-2024, US$ million

Table 6. Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Company, 2019-2024

Table 7. Global Point-of-care Testing (POCT) for Inflammatory Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share by Company, 2019-2024

Table 9. Global Point-of-care Testing (POCT) for Inflammatory Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Point-of-care Testing (POCT) for Inflammatory Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Point-of-care Testing (POCT) for Inflammatory Mergers & Acquisitions, Expansion Plans

Table 12. Global Point-of-care Testing (POCT) for Inflammatory Manufacturers Product Type

Table 13. China Point-of-care Testing (POCT) for Inflammatory Revenue by Company, 2019-2024, US$ million

Table 14. China Point-of-care Testing (POCT) for Inflammatory Revenue Market Share by Company, 2019-2024

Table 15. China Point-of-care Testing (POCT) for Inflammatory Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Point-of-care Testing (POCT) for Inflammatory Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Point-of-care Testing (POCT) for Inflammatory Import & Export Trends

Table 19. Main Sources of China Point-of-care Testing (POCT) for Inflammatory Import

Table 20. Export Destination of China Point-of-care Testing (POCT) for Inflammatory

Table 21. Global Headquarters and Manufacturing Base of Point-of-care Testing (POCT) for Inflammatory Manufacturers

Table 22. Global Major Manufacturers, Point-of-care Testing (POCT) for Inflammatory Capacity Expansion and Future Plans

Table 23. Global Point-of-care Testing (POCT) for Inflammatory Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Point-of-care Testing (POCT) for Inflammatory Production by Region, 2019-2024, (K Units)

Table 25. Global Point-of-care Testing (POCT) for Inflammatory Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Point-of-care Testing (POCT) for Inflammatory Upstream (Raw Materials)

Table 27. Global Point-of-care Testing (POCT) for Inflammatory Typical Customers

Table 28. Point-of-care Testing (POCT) for Inflammatory Typical Distributors

Table 29. By Type, Global Point-of-care Testing (POCT) for Inflammatory Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Point-of-care Testing (POCT) for Inflammatory Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Point-of-care Testing (POCT) for Inflammatory Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Point-of-care Testing (POCT) for Inflammatory Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Point-of-care Testing (POCT) for Inflammatory Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Point-of-care Testing (POCT) for Inflammatory Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share, 2019-2030

Table 37. By Country, Global Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2019-2030

Table 39. Roche Company Information, Head Office, Market Area and Industry Position

Table 40. Roche Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 41. Roche Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Roche Company Profile and Main Business

Table 43. Roche Recent Developments

Table 44. Abbott Company Information, Head Office, Market Area and Industry Position

Table 45. Abbott Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 46. Abbott Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Abbott Company Profile and Main Business

Table 48. Abbott Recent Developments

Table 49. Siemens Healthineers Company Information, Head Office, Market Area and Industry Position

Table 50. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 51. Siemens Healthineers Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Siemens Healthineers Company Profile and Main Business

Table 53. Siemens Healthineers Recent Developments

Table 54. BioMerieux Company Information, Head Office, Market Area and Industry Position

Table 55. BioMerieux Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 56. BioMerieux Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. BioMerieux Company Profile and Main Business

Table 58. BioMerieux Recent Developments

Table 59. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

Table 60. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 61. Bio-Rad Laboratories Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Bio-Rad Laboratories Company Profile and Main Business

Table 63. Bio-Rad Laboratories Recent Developments

Table 64. Assure Tech Company Information, Head Office, Market Area and Industry Position

Table 65. Assure Tech Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 66. Assure Tech Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Assure Tech Company Profile and Main Business

Table 68. Assure Tech Recent Developments

Table 69. Guangzhou Wondfo Biotech Co.,Ltd. Company Information, Head Office, Market Area and Industry Position

Table 70. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 71. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Guangzhou Wondfo Biotech Co.,Ltd. Company Profile and Main Business

Table 73. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments

Table 74. Wuhan Easy Diagnosis Company Information, Head Office, Market Area and Industry Position

Table 75. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 76. Wuhan Easy Diagnosis Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Wuhan Easy Diagnosis Company Profile and Main Business

Table 78. Wuhan Easy Diagnosis Recent Developments

Table 79. Getein Biotech Company Information, Head Office, Market Area and Industry Position

Table 80. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 81. Getein Biotech Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Getein Biotech Company Profile and Main Business

Table 83. Getein Biotech Recent Developments

Table 84. Beijing Hotgen Biotech Co.,ltd. Company Information, Head Office, Market Area and Industry Position

Table 85. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 86. Beijing Hotgen Biotech Co.,ltd. Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Beijing Hotgen Biotech Co.,ltd. Company Profile and Main Business

Table 88. Beijing Hotgen Biotech Co.,ltd. Recent Developments

Table 89. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Company Information, Head Office, Market Area and Industry Position

Table 90. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 91. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Company Profile and Main Business

Table 93. Shanghai Upper Bio-Tech Pharma Co.,Ltd. Recent Developments

Table 94. Qingdao Hightop Biotech Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 95. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 96. Qingdao Hightop Biotech Co., Ltd. Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Qingdao Hightop Biotech Co., Ltd. Company Profile and Main Business

Table 98. Qingdao Hightop Biotech Co., Ltd. Recent Developments

Table 99. Goldsite Diagnostics Inc. Company Information, Head Office, Market Area and Industry Position

Table 100. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 101. Goldsite Diagnostics Inc. Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Goldsite Diagnostics Inc. Company Profile and Main Business

Table 103. Goldsite Diagnostics Inc. Recent Developments

Table 104. Genrui Biotech Inc Company Information, Head Office, Market Area and Industry Position

Table 105. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 106. Genrui Biotech Inc Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Genrui Biotech Inc Company Profile and Main Business

Table 108. Genrui Biotech Inc Recent Developments

Table 109. Hipro Biotechnology CO.,LTD Company Information, Head Office, Market Area and Industry Position

Table 110. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Models, Specifications and Application

Table 111. Hipro Biotechnology CO.,LTD Point-of-care Testing (POCT) for Inflammatory Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Hipro Biotechnology CO.,LTD Company Profile and Main Business

Table 113. Hipro Biotechnology CO.,LTD Recent Developments

List of Figure

Figure 1. Point-of-care Testing (POCT) for Inflammatory Picture

Figure 2. By Revenue, Global Point-of-care Testing (POCT) for Inflammatory Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Point-of-care Testing (POCT) for Inflammatory Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Point-of-care Testing (POCT) for Inflammatory Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Point-of-care Testing (POCT) for Inflammatory Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Point-of-care Testing (POCT) for Inflammatory Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Point-of-care Testing (POCT) for Inflammatory Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Point-of-care Testing (POCT) for Inflammatory Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Point-of-care Testing (POCT) for Inflammatory Share of Global Market, 2019-2030

Figure 10. Global Point-of-care Testing (POCT) for Inflammatory Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 11. Global Point-of-care Testing (POCT) for Inflammatory Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023

Figure 12. China Point-of-care Testing (POCT) for Inflammatory Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 13. China Point-of-care Testing (POCT) for Inflammatory Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 14. China Point-of-care Testing (POCT) for Inflammatory Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Point-of-care Testing (POCT) for Inflammatory Domestic VS Export, 2023

Figure 16. Global Point-of-care Testing (POCT) for Inflammatory Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Point-of-care Testing (POCT) for Inflammatory Capacity Market Share by Region, 2023 VS 2029

Figure 18. Global Point-of-care Testing (POCT) for Inflammatory Production Market Share & Forecast by Region, 2019-2030

Figure 19. Point-of-care Testing (POCT) for Inflammatory Industry Chain

Figure 20. Point-of-care Testing (POCT) for Inflammatory Procurement Model

Figure 21. Point-of-care Testing (POCT) for Inflammatory Sales Model

Figure 22. Point-of-care Testing (POCT) for Inflammatory Sales Channels, Direct Sales and Distribution

Figure 23. Based on Immunochromatography

Figure 24. Based on Chemiluminescence

Figure 25. Based on Microfluidic Chip

Figure 26. By Type, Global Point-of-care Testing (POCT) for Inflammatory Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share, 2019-2030

Figure 28. By Type, Global Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global Point-of-care Testing (POCT) for Inflammatory Price, 2019-2030, (US$/Unit)

Figure 31. C-Reactive Protein (CRP) Test

Figure 32. Procalcitonin (PCT) Test

Figure 33. Interleukin 6 (IL-6) Test

Figure 34. Serum amyloid A (SAA) Test

Figure 35. Others

Figure 36. By Application, Global Point-of-care Testing (POCT) for Inflammatory Revenue, 2019-2030, US$ Million

Figure 37. By Application, Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share, 2019-2030

Figure 38. By Application, Global Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 39. By Application, Global Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2019-2030

Figure 40. By Application, Global Point-of-care Testing (POCT) for Inflammatory Price, 2019-2030, (US$/Unit)

Figure 41. By Region, Global Point-of-care Testing (POCT) for Inflammatory Revenue Market Share, 2019-2030

Figure 42. By Region, Global Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2019-2030

Figure 43. North America Point-of-care Testing (POCT) for Inflammatory Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, North America Point-of-care Testing (POCT) for Inflammatory Revenue Market Share, 2023

Figure 45. Europe Point-of-care Testing (POCT) for Inflammatory Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country, Europe Point-of-care Testing (POCT) for Inflammatory Revenue Market Share, 2023

Figure 47. Asia Pacific Point-of-care Testing (POCT) for Inflammatory Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country/Region, Asia Pacific Point-of-care Testing (POCT) for Inflammatory Revenue Market Share, 2023

Figure 49. South America Point-of-care Testing (POCT) for Inflammatory Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. By Country, South America Point-of-care Testing (POCT) for Inflammatory Revenue Market Share, 2023

Figure 51. Middle East & Africa Point-of-care Testing (POCT) for Inflammatory Revenue & Forecasts, 2019-2030, US$ Million

Figure 52. U.S. Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 53. By Company, U.S. Point-of-care Testing (POCT) for Inflammatory Market Share, 2023

Figure 54. By Type, U.S. Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 55. By Application, U.S. Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 56. Europe Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 57. By Company, Europe Point-of-care Testing (POCT) for Inflammatory Market Share, 2023

Figure 58. By Type, Europe Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 59. By Application, Europe Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 60. China Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 61. By Company, China Point-of-care Testing (POCT) for Inflammatory Market Share, 2023

Figure 62. By Type, China Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 63. By Application, China Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 64. Japan Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 65. By Company, Japan Point-of-care Testing (POCT) for Inflammatory Market Share, 2023

Figure 66. By Type, Japan Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 67. By Application, Japan Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 68. South Korea Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 69. By Company, South Korea Point-of-care Testing (POCT) for Inflammatory Market Share, 2023

Figure 70. By Type, South Korea Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 71. By Application, South Korea Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 72. Southeast Asia Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 73. By Company, Southeast Asia Point-of-care Testing (POCT) for Inflammatory Market Share, 2023

Figure 74. By Type, Southeast Asia Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 75. By Application, Southeast Asia Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 76. India Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 77. By Company, India Point-of-care Testing (POCT) for Inflammatory Market Share, 2023

Figure 78. By Type, India Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 79. By Application, India Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 80. Middle East & Asia Point-of-care Testing (POCT) for Inflammatory Sales Volume, 2019-2030, (K Units)

Figure 81. By Company, Middle East & Asia Point-of-care Testing (POCT) for Inflammatory Market Share, 2023

Figure 82. By Type, Middle East & Asia Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 83. By Application, Middle East & Asia Point-of-care Testing (POCT) for Inflammatory Sales Volume Market Share, 2023 VS 2029

Figure 84. Research Methodology

Figure 85. Breakdown of Primary Interviews

Figure 86. Bottom-up Approaches

Figure 87. Top-down Approaches